1-5 of 5
Gina Kirsammer
Close
Sort by
Journal Articles

USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism

Johanna Melo-Cardenas, Yuanming Xu, Juncheng Wei, Can Tan, Sinyi Kong, Beixue Gao, Elena Montauti, Gina Kirsammer, Jonathan D. Licht, Jindan Yu, Peng Ji, John D. Crispino, Deyu Fang
Journal: Blood
Blood (2018) 132 (4): 423–434.
https://doi.org/10.1182/blood-2017-10-811760
Published: 2018
Includes: Supplemental data
Journal Articles

A PDZ-Binding Motif in DCAF7 Maintains Hematopoietic Homeostasis and Prevents Malignancy in DS-AMKL

Gina Kirsammer, PhD, Rachael F Schultz, BA, Ritika Rastogi, BA, Sandeep Gurbuxani, MBBS, PhD, John Crispino, PhD
Journal: Blood
Blood (2016) 128 (22): 1205.
https://doi.org/10.1182/blood.V128.22.1205.1205
Published: 2016
Journal Articles

Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation

Benjamin Goldenson, Gina Kirsammer, Monika J. Stankiewicz, Qiang Jeremy Wen, John D. Crispino
Journal: Blood
Blood (2015) 125 (13): 2141–2150.
https://doi.org/10.1182/blood-2014-12-615401
Published: 2015
Includes: Supplemental data
Journal Articles

Development of a Mouse Model of DS Megakaryoblastic Leukemia and Identification of the Hsa21 Gene DYRK1A as a Prominent Contributor to DS-AMKL

Sebastien Malinge, PhD, Gina Kirsammer, PhD, Meghan Bliss-Moreau, Timothy M Chlon, Lauren Diebold, Stella T Chou, MD, Mitchell Weiss, MD, Sandeep Gurbuxani, MBBS, PhD, John Crispino, PhD
Journal: Blood
Blood (2010) 116 (21): 469.
https://doi.org/10.1182/blood.V116.21.469.469
Published: 2010
Journal Articles

Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome

Gina Kirsammer, Sarah Jilani, Hui Liu, Elizabeth Davis, Sandeep Gurbuxani, Michelle M. Le Beau, John D. Crispino
Journal: Blood
Blood (2008) 111 (2): 767–775.
https://doi.org/10.1182/blood-2007-04-085670
Published: 2008
Includes: Supplemental data